KAYS - Kaya Holdings, Inc.
0.036
0.001 2.778%
Share volume: 824
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
0.03%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-22-2024 | |
| Total revenue | 3.000 K | |
| Cost of revenue | 272.000 | |
| Gross profit | 2.728 K | |
| Operating expenses | 1.105 M | |
| Selling general and admin | 1.105 M | |
| Research and development | 0.000 | |
| Total expenses | 1.141 M | |
| Operating income | -1.140 M | |
| Ebit | -2.225 M | |
| Pretax income | -2.495 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -2.495 M | |
